Michael Bonney
Chairman at AUTOLUS THERAPEUTICS PLC
Net worth: 5 M $ as of 30/12/2024
Profile
Michael W. Bonney is a businessperson who has been at the helm of 7 different companies. He occupies the position of Chairman at Alnylam Pharmaceuticals, Inc., Chairman for Kaleido Biosciences, Inc. and Chairman for Magenta Therapeutics, Inc. He is also on the board of Bristol Myers Squibb Co., Life Sciences Cares and X-Biotix Therapeutics, Inc. and Chairman of Bates College. In the past he held the position of Chairman of Rare LLC (Virginia), Director-National Business at Zeneca Pharmaceuticals, Partner at Third Rock Ventures LLC, Vice President-Sales & Marketing at Biogen, Inc., Director at Cubist Pharmaceuticals LLC, Chairman of Gulf of Maine Research Institute and Director at Biotechnology Innovation Organization. Mr. Bonney received an undergraduate degree from Bates College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
15/05/2024 | 20,029 ( 0.02% ) | 5 M $ | 30/12/2024 |
Latest news about Michael Bonney
Michael Bonney active positions
Companies | Position | Start |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director/Board Member | 04/01/2023 |
AUTOLUS THERAPEUTICS PLC | Chairman | 31/03/2024 |
X-Biotix Therapeutics, Inc.
![]() X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Director/Board Member | 20/04/2020 |
Gulf of Maine Research Institute
![]() Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Gulf of Maine Research Institute operates a research institute that provides collaborative solutions to ocean challenges. The non-profit company is based in Portland, ME. The company was founded in 1994. The CEO is Glenn T. Prickett. | Director/Board Member | - |
Dunad Therapeutics Ltd.
![]() Dunad Therapeutics Ltd. BiotechnologyHealth Technology Dunad Therapeutics Ltd. is a British biopharmaceutical company that specializes in developing targeted protein degradation therapies. Dunad was founded in 2020 and is headquartered in an undisclosed location, with operations in both the UK and the US. The company's platform allows for selective degradation through direct target modification using tuneable mono-valent small molecules, which enables the development of more drug-like, orally bioavailable, and CNS-accessible protein degraders. The company is backed by Epidarex Capital. Pearl Shirley Huang has been the CEO of the company since 2022. | Chairman | 08/01/2023 |
Life Sciences Cares
![]() Life Sciences Cares Miscellaneous Commercial ServicesCommercial Services Life Sciences Cares operates an organization aimed at eradicating poverty. The private company is based in Cambridge and was founded by Robert J. Perez. | Director/Board Member | - |
Former positions of Michael Bonney
Companies | Position | End |
---|---|---|
KALEIDO BIOSCIENCES, INC. | Chief Executive Officer | 20/08/2018 |
BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 02/08/2021 |
MAGENTA THERAPEUTICS | Chairman | 02/08/2021 |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Michael Bonney
Bates College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 8 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOGEN INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
Private companies | 23 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
abrdn Healthcare Investors
![]() abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA. | Miscellaneous |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Whitehead Institute for Biomedical Research
![]() Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
abrdn Healthcare Opportunities Fund
![]() abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
Trius Therapeutics, Inc.
![]() Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Global Blood Therapeutics, Inc.
![]() Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
abrdn Life Sciences Investors
![]() abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA. | Miscellaneous |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Zeneca Pharmaceuticals
![]() Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
NPS Pharmaceuticals, Inc.
![]() NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
![]() Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
Gulf of Maine Research Institute
![]() Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Gulf of Maine Research Institute operates a research institute that provides collaborative solutions to ocean challenges. The non-profit company is based in Portland, ME. The company was founded in 1994. The CEO is Glenn T. Prickett. | Commercial Services |
Life Sciences Cares
![]() Life Sciences Cares Miscellaneous Commercial ServicesCommercial Services Life Sciences Cares operates an organization aimed at eradicating poverty. The private company is based in Cambridge and was founded by Robert J. Perez. | Commercial Services |
Dunad Therapeutics Ltd.
![]() Dunad Therapeutics Ltd. BiotechnologyHealth Technology Dunad Therapeutics Ltd. is a British biopharmaceutical company that specializes in developing targeted protein degradation therapies. Dunad was founded in 2020 and is headquartered in an undisclosed location, with operations in both the UK and the US. The company's platform allows for selective degradation through direct target modification using tuneable mono-valent small molecules, which enables the development of more drug-like, orally bioavailable, and CNS-accessible protein degraders. The company is backed by Epidarex Capital. Pearl Shirley Huang has been the CEO of the company since 2022. | Health Technology |
Rare LLC (Virginia)
![]() Rare LLC (Virginia) Miscellaneous Commercial ServicesCommercial Services Rare LLC is an international conservation and development organization that is based in Arlington, VA. Brett Jenks has been the CEO of the private company since 2000. Rare LLC uses behavioral insights to inspire change in order to promote the thriving of both people and nature. | Commercial Services |
X-Biotix Therapeutics, Inc.
![]() X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Health Technology |
Pharmaceutical Manufacturers Association of America | |
Tekla Capital Management LLC
![]() Tekla Capital Management LLC Investment ManagersFinance Tekla Capital Management LLC (Tekla) is an asset manager headquartered in Boston, Massachusetts. The firm was formerly known as Hambrecht & Quist Capital Management LLC. They are a subsidiary of abrdn Inc., ultimately owned by abrdn Plc (LSE: ABDN) in Great Britain. Tekla serves as an investment adviser for various closed-end funds. | Finance |
Magenta Therapeutics, Inc.
![]() Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
abrdn World Healthcare Fund
![]() abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Tekla World Healthcare Fund is a closed-end management investment company, which engages in investing in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities and debt securities. The company was founded on March 5, 2015 and is headquartered in Boston, MA. | Miscellaneous |
- Stock Market
- Insiders
- Michael Bonney